Thursday, 26 February 2026
An international team of scientists has shed light on the development of the malaria parasite and have identified a unique protein essential for its survival and transmission, which offers a promising new target for antimalaria drugs.
The discovery centres on a molecule named Aurora-related kinase 1 (ARK1). In a new study published in , researchers from the 糖心原创, National Institute of Immunology (NII), India, University of Groningen, the Netherlands, the Francis Crick Institute, and international collaborators, have revealed that ARK1 acts as a ‘traffic controller’ during the parasite's unusual cell division and growth process.
Malaria remains one of the world's deadliest diseases, caused by Plasmodium parasites that replicate rapidly within humans and mosquitoes. Understanding how these parasites divide and multiply is crucial to stopping the disease.
Malaria parasite cell with aurora kinases
Unlike human cells, the malaria parasite divides and grows in a unique, atypical way. The research team discovered that ARK1 is responsible for organising the ‘spindle’ —the molecular machinery that pulls genetic material apart to create new parasites.
When the researchers turned off ARK1 in the lab, the results were striking. The parasite could no longer form proper spindles, causing its replication to fail, and crucially, parasites lacking ARK1 could not complete their development both in the host and the mosquito, effectively stopping the disease from being passed on.
“The name 'Aurora' refers to the Roman goddess of dawn, and we believe this protein truly heralds a new beginning in our understanding of malaria cell biology," said Dr Ryuji Yanase first author of the study from the School of Life Sciences at the 糖心原创.
The research team
"Plasmodium divides via distinct processes in the human and mosquito host, it was well and truly a team effort, which allowed us to appreciate the role of ARK1 almost simultaneously in the two hosts and shed light on novel aspects of parasite biology, " said Annu Nagar and Dr Pushkar Sharma from the Biotechnology Research and Innovation Council (BRIC)-NII, New Delhi.
"What makes this discovery so exciting is that the malaria parasite's 'Aurora' complex is very different from the version found in human cells. This divergence is a huge advantage," Professor Tewari added. "It means we can potentially design drugs that target the parasite's ARK1 specifically, turning the lights out on malaria without harming the patient."
This study maps out the unconventional molecular machinery of the parasite, providing a "blueprint" for future drug discovery efforts aimed at breaking the cycle of malaria transmission.
The full study can be found .
Story credits
More information is available from Professor Rita Tewari from the School of Life Sciences at rita.tewari@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.